CFP
PBE icon

Cornerstone Financial Partners’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Cornerstone Financial Partners’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,284
Closed -$216K – 171
2015
Q4 		$216K Buy
+4,284
New +$212K 0.08% 131

Other funds holding PBE

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
CAS
Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

Cornerstone Financial Partners's PBE Position: Q1 2016 in Review

Cornerstone Financial Partners sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2016, closing a stake of 4,284 shares — an estimated $216K sold.

Cornerstone Financial Partners first reported a position in PBE in Q4 2015 and held it in 1 quarter. The position peaked at $216K in Q4 2015. 71 funds tracked by Wall St. Rank hold PBE as of Q1 2016.

  • Cornerstone Financial Partners reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2016 after selling out during the quarter.
  • Cornerstone Financial Partners sold 4,284 Invesco Biotechnology & Genome ETF shares in Q1 2016, an estimated $216K.
  • Cornerstone Financial Partners first reported a position in Invesco Biotechnology & Genome ETF in Q4 2015 and held it in 1 quarter.
  • Cornerstone Financial Partners's Invesco Biotechnology & Genome ETF position peaked at $216K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2016.

Based on Cornerstone Financial Partners's 13F filing for Q1 2016, filed 6 May 2016.